Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
16-hexaoxo-3-phenylicosahydropyrrolo[1
CC1=CC=C(C=C1NC1=NC(=CC=N1)C1=CN=CC=C1)C(=O)NC1C=C(C=C(C=1)C(F)(F)F)N1C=NC(C)=C1
InChiKey: TYQIADLRQRJBLH-UHFFFAOYSA-N
2014 May-Jun
and some types of gastroenteritis
Empagliflozin - CAS# 864070-44-0 Catalog No.:M10131-10 16-hexaoxo-3-phenylicosahydropyrrolo[1Empagliflozin, also known as BI10773 (trade name Jardiance), is drug approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company. Empagliflozin is an inhibitor of the sodium glucose co transporter 2 (SGLT 2), and causes sugar in the blood to be absorbed by the kidneys and eliminated in urine. Empagliflozin is an inhibitor of the sodium glucose co transporter 2 (SGLT 2), which is
US$ 186.60
US$ 773.40
US$ 838.00
US$ 415.55
US$ 243.50
US$ 180.65
US$ 150.80
US$ 544.30
US$ 376.98
US$ 199.99
US$ 114.99
US$ 225.00
US$ 235.47
US$ 506.48